Anagenics Ltd has released a press release.
FY2019 Financial Results
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Patent for Improved Midkine Antibody Allowed in Europe
- CDY Signs Distribution Agreement for EVOLIS in South Korea
- Response to Appendix 4C Query
- Cellmid Sets Another Sales Record in Q4 FY2019
- Cellmids Evolis Registered in European Union (EU)
Later from Anagenics
- New Evolis Distribution & Supply Agreements - China & Europe
- New TV Shopping Agreement for Evolis
- Cellmid Signs Trading Agreement With API/Priceline
- Cellmid Reports on QVC Sales
- Key Midkine Antibody Patents Granted in the US and Europe
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics